19-52582309-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_018260.3(ZNF701):c.250G>A(p.Asp84Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000997 in 1,614,050 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_018260.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZNF701 | NM_018260.3 | c.250G>A | p.Asp84Asn | missense_variant | 4/4 | ENST00000391785.8 | NP_060730.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZNF701 | ENST00000391785.8 | c.250G>A | p.Asp84Asn | missense_variant | 4/4 | 1 | NM_018260.3 | ENSP00000375662.2 |
Frequencies
GnomAD3 genomes AF: 0.000151 AC: 23AN: 152196Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000151 AC: 38AN: 251262Hom.: 0 AF XY: 0.000162 AC XY: 22AN XY: 135802
GnomAD4 exome AF: 0.0000944 AC: 138AN: 1461736Hom.: 1 Cov.: 31 AF XY: 0.0000963 AC XY: 70AN XY: 727146
GnomAD4 genome AF: 0.000151 AC: 23AN: 152314Hom.: 0 Cov.: 33 AF XY: 0.000134 AC XY: 10AN XY: 74468
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 09, 2024 | The c.448G>A (p.D150N) alteration is located in exon 5 (coding exon 4) of the ZNF701 gene. This alteration results from a G to A substitution at nucleotide position 448, causing the aspartic acid (D) at amino acid position 150 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at